Population screening

Population screening is the process of assessing the prevalence of a particular trait in the entire population or in a subgroup of the population. Genetic testing or other means are used to determine the presence of biomarkers or genetic characteristics.


Latest Research and Reviews

News and Comment

  • News and Views |

    High post-challenge glucose plasma concentrations that are observed during pregnancy screening can help to identify women who are at an increased likelihood of later health issues, predominantly cardiovascular diseases. This finding offers a unique opportunity to improve the health of women, but further work is required to translate into clinical benefits.

    • Rosa Corcoy
  • News and Views |

    In a landmark analysis, investigators of the Multicentric Italian Lung Detection (MILD) trial have confirmed 10-year mortality reductions with lung cancer screening using low-dose helical CT (LDCT). These data complement the reduced lung cancer-specific mortality reported in the National Lung Screening Trial and reinforce the rationale for broad implementation of LDCT screening in high-risk populations.

    • Matthew B. Schabath
    •  & Denise R. Aberle
  • News and Views |

    The global burden of cardiovascular disease morbidity and mortality demands increased awareness of effective prevention strategies by patients, communities and health-care providers. The new 2019 ACC/AHA guidelines provide evidence-based, preventive recommendations for patients without known cardiovascular disease, focusing on risk estimation, a healthy lifestyle and selective indications for pharmacotherapy.

    • Rhanderson Cardoso
    •  & Khurram Nasir
  • Research Highlights |

    High-sensitivity troponin I levels are positively and strongly linked with incident coronary heart disease, heart failure hospitalization and all-cause mortality in individuals without known cardiovascular disease.

    • Karina Huynh
  • News and Views |

    The analyses in the 2017 Global Burden of Disease Study demonstrate the growing burden of chronic kidney disease (CKD), mainly driven by population ageing; absolute levels for every CKD metric considered rose significantly, whereas age-standardized rates were fairly stable. The prevalence of key metabolic CKD risk factors, particularly obesity, also show a worrying increase.

    • Simon D. S. Fraser
    •  & Paul J. Roderick